Mitochondrial function and dysfunction in exercise and insulin resistance

Applied Physiology, Nutrition and Metabolism

Volumn 34, Issue 3, 2009, Pages 440-446

  Holloway, Graham P ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Fatty acid oxidation; Insulin resistance; Mitochondria; Mitochondrial biogenesis; Obesity; Plasma membrane transport

Indexed keywords

FATTY ACID;

ENERGY METABOLISM; EXERCISE; HUMAN; INSULIN RESISTANCE; METABOLISM; MITOCHONDRION; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ENERGY METABOLISM; EXERCISE; FATTY ACIDS; HUMANS; INSULIN RESISTANCE; MITOCHONDRIA; SIGNAL TRANSDUCTION;

EID: 67651209198     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H09-028     Document Type: Review

References (61)

1. Alkhateeb, H., Chabowski, A., Glatz, J.F., Luiken, J.F., and Bonen, A. 2007. Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity. Am. J. Physiol. Endocrinol. Metab. 293: E783-E793. doi:10.1152/ajpendo.00685.2006. PMID:17550999.
2. Bandyopadhyay, G.K., Yu, J.G., Ofrecio, J., and Olefsky, J.M. 2006. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes, 55: 2277-2285. doi:10.2337/db06-0062. PMID:16873691.
3. Belfort, R., Mandarino, L., Kashyap, S., Wirfel, K., Pratipanawatr, T., Berria, R., et al. 2005. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes, 54: 1640- 1648. doi:10.2337/diabetes.54.6.1640. PMID:15919784.
4. Benton, C.R., Han, X.X., Febbraio, M., Graham, T.E., and Bonen, A. 2006. Inverse relationship between PGC-1a protein expression and triacylglycerol accumulation in rodent skeletal muscle. J. Appl. Physiol. 100: 377-383. doi:10.1152/japplphysiol.00781.2005. PMID:16223979.
5. Bezaire, V., Bruce, C.R., Heigenhauser, G.J., Tandon, N.N., Glatz, J.F., Luiken, J.J., et al. 2006. Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation. Am. J. Physiol. Endocrinol. Metab. 290: E509-E515. doi:10.1152/ajpendo.00312.2005. PMID:16219667.
6. Boden, G. 2003. Effects of free fatty acids on gluconeogenesis and glycogenolysis. Life Sci. 72: 977-988. doi:10.1016/S00243205(02)02350-0. PMID:12495777.
7. Boden, G., Chen, X., Ruiz, J., White, J.V., and Rossetti, L. 1994. Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93: 2438-2446. doi:10.1172/JCI117252. PMID:8200979.
8. Bonen, A., Campbell, S.E., Benton, C.R., Chabowski, A., Coort, S.L., Han, X.X., et al. 2004a. Regulation of fatty acid transport by fatty acid translocase/CD36. Proc. Nutr. Soc. 63: 245-249. doi:10.1079/PNS2004331. PMID:15294038.
9. Bonen, A., Parolin, M.L., Steinberg, G.R., Calles-Escandon, J., Tandon, N.N., Glatz, J.F., et al. 2004b. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 18: 1144-1146. PMID:15132977.
10. Boushel, R., Gnaiger, E., Schjerling, P., Skovbro, M., Kraunsoe, R., and Dela, F. 2007. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia, 50: 790-796. doi:10.1007/s00125-007-0594-3. PMID:17334651.
11. Bruce, C.R., Mertz, V.A., Heigenhauser, G.J., and Dyck, D.J. 2005. The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes, 54: 3154-3160. doi:10.2337/diabetes.54.11.3154. PMID:16249439.
12. Campbell, S.E., Tandon, N.N., Woldegiorgis, G., Luiken, J.J., Glatz, J.F., and Bonen, A. 2004. A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J. Biol. Chem. 279: 36235-36241. doi:10.1074/jbc.M400566200. PMID:15161924.
13. Coort, S.L., Hasselbaink, D.M., Koonen, D.P., Willems, J., Coumans, W.A., Chabowski, A., et al. 2004. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Diabetes, 53: 1655-1663. doi:10.2337/diabetes.53.7.1655. PMID:15220187.
14. De Filippis, E., Alvarez, G., Berria, R., Cusi, K., Everman, S., Meyer, C., and Mandarino, L.J. 2008. Insulin resistant muscle is exercise resistant: evidence for reduced response of nuclear encoded mitochondrial genes to exercise. Am. J. Physiol. Endocrinol. Metab. 294: E607-E614. doi:10.1152/ajpendo.00729.2007. PMID:18182465.
15. Dresner, A., Laurent, D., Marcucci, M., Griffin, M.E., Dufour, S., Cline, G.W., et al. 1999. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 103: 253-259. doi:10.1172/JCI5001. PMID:9916137.
16. Fan, M., Rhee, J., St-Pierre, J., Handschin, C., Puigserver, P., Lin, J., et al. 2004. Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1α: modulation by p38 MAPK. Genes Dev. 18: 278-289. doi:10.1101/gad.1152204. PMID:14744933.
17. Garcia-Roves, P., Huss, J.M., Han, D.H., Hancock, C.R., IglesiasGutierrez, E., Chen, M., and Holloszy, J.O. 2007. Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 104: 10709-10713. doi:10.1073/pnas.0704024104. PMID:17548828.
18. Han, X.X., Chabowski, A., Tandon, N.N., Calles-Escandon, J., Glatz, J.F., Luiken, J.J., and Bonen, A. 2007. Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese zucker rat muscle. Am. J. Physiol. Endocrinol. Metab. 293: E566-E575. doi:10.1152/ajpendo.00106.2007. PMID:17519284.
19. Holland, W.L., Brozinick, J.T., Wang, L.P., Hawkins, E.D., Sargent, K.M., Liu, Y., et al. 2007. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 5: 167-179. doi:10.1016/j.cmet.2007.01.002. PMID:17339025.
20. Holloway, G.P., Bezaire, V., Heigenhauser, G.J., Tandon, N.N., Glatz, J.F., Luiken, J.J., et al. 2006. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise. J. Physiol. 571: 201-210. doi:10.1113/jphysiol.2005.102178. PMID:16357012.
21. Holloway, G.P., Thrush, A.B., Heigenhauser, G.J., Tandon, N.N., Dyck, D.J., Bonen, A., and Spriet, L.L. 2007. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women. Am. J. Physiol. Endocrinol. Metab. 292: E1782-E1789. doi:10.1152/ajpendo.00639.2006. PMID:17311893.
22. Holloway, G.P., Perry, C.G., Thrush, A.B., Heigenhauser, G.J., Dyck, D.J., Bonen, A., and Spriet, L.L. 2008. PGC-1α's relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1a and PGC-1β protein. Am. J. Physiol. Endocrinol. Metab. 294: E1060-E1069. doi:10.1152/ajpendo.00726.2007. PMID:18349111.
23. Holloway G.P., Benton C., Mullen K.L., Yoshida Y., Snook L.A., Han X.X., et al. 2009. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation. Am J Physiol Endocrinol Metab. [Epub ahead of print.] PMID:19141681.
24. Kelley, D.E., Goodpaster, B., Wing, R.R., and Simoneau, J.A. 1999. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am. J. Physiol. 277: E1130-E1141. PMID:10600804.
25. Kelley, D.E., He, J., Menshikova, E.V., and Ritov, V.B. 2002. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes, 51: 2944-2950. doi:10.2337/diabetes.51.10. 2944.PMID:12351431.
26. Kim, J.Y., Hickner, R.C., Cortright, R.L., Dohm, G.L., and Houmard, J.A. 2000. Lipid oxidation is reduced in obese human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 279: E1039-E1044. PMID:11052958.
27. King, K.L., Stanley, W.C., Rosca, M., Kerner, J., Hoppel, C.L., and Febbraio, M. 2007. Fatty acid oxidation in cardiac and skeletal muscle mitochondria is unaffected by deletion of CD36. Arch. Biochem. Biophys. 467: 234-238. doi:10.1016/j.abb.2007.08.020. PMID:17904092.
28. Knutti, D., Kressler, D., and Kralli, A. 2001. Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. Proc. Natl. Acad. Sci. U.S.A. 98: 9713-9718. doi:10.1073/pnas.171184698. PMID:11481440.
29. Koves, T.R., Noland, R.C., Bates, A.L., Henes, S.T., Muoio, D.M., and Cortright, R.N. 2005. Subsarcolemmal and intermyofibrillar mitochondria play distinct roles in regulating skeletal muscle fatty acid metabolism. Am. J. Physiol. Cell Physiol. 288: C1074-C1082. doi:10.1152/ajpcell.00391.2004. PMID:15647392.
30. Koves, T.R., Ussher, J.R., Noland, R.C., Slentz, D., Mosedale, M., Ilkayeva, O., et al. 2008. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7: 45-56. doi:10.1016/j.cmet.2007.10.013. PMID:18177724.
31. Krogh, A., and Lindhard, J. 1920. The relative value of fat and carbohydrate as sources of muscular energy: with appendices on the correlation between standard metabolism and the respiratory quotient during rest and work. Biochem. J. 14: 290-363. PMID:16742941.
32. Krssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S.M., Rothman, D.L., et al. 1999. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia, 42: 113-116. doi:10.1007/s001250051123. PMID:10027589.
33. Kruszynska, Y.T., Worrall, D.S., Ofrecio, J., Frias, J.P., Macaraeg, G., and Olefsky, J.M. 2002. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation. J. Clin. Endocrinol. Metab. 87: 226-234. doi:10.1210/jc.87.1.226. PMID:11788651.
34. Lehman, J.J., Barger, P.M., Kovacs, A., Saffitz, J.E., Medeiros, D.M., and Kelly, D.P. 2000. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106: 847-856. doi:10.1172/JCI10268. PMID:11018072.
35. McGarry, J.D., Mills, S.E., Long, C.S., and Foster, D.W. 1983. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in nonhepatic tissues of the rat. Biochem. J. 214: 21-28. PMID:6615466.
36. Mogensen, M., Sahlin, K., Fernstrom, M., Glintborg, D., Vind, B.F., Beck-Nielsen, H., and Hojlund, K. 2007. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes, 56: 1592-1599. doi:10.2337/db06-0981. PMID:17351150.
37. Mootha, V.K., Lindgren, C.M., Eriksson, K.F., Subramanian, A., Sihag, S., Lehar, J., et al. 2003. PGC-1a-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34: 267-273. doi:10.1038/ng1180. PMID:12808457.
38. Morino, K., Petersen, K.F., Dufour, S., Befroy, D., Frattini, J., Shatzkes, N., et al. 2005. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 115: 3587-3593. doi:10.1172/JCI25151. PMID:16284649.
39. Odland, L.M., Heigenhauser, G.J., Lopaschuk, G.D., and Spriet, L.L. 1996. Human skeletal muscle malonyl-CoA at rest and during prolonged submaximal exercise. Am. J. Physiol. 270: E541-E544. PMID:8638703.
40. Odland, L.M., Howlett, R.A., Heigenhauser, G.J., Hultman, E., and Spriet, L.L. 1998. Skeletal muscle malonyl-CoA content at the onset of exercise at varying power outputs in humans. Am. J. Physiol. 274: E1080-E1085. PMID:9611159.
41. Pan, D.A., Lillioja, S., Kriketos, A.D., Milner, M.R., Baur, L.A., Bogardus, C., et al. 1997. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes, 46: 983-988. doi:10.2337/diabetes.46.6.983. PMID:9166669.
42. Patti, M.E., Butte, A.J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., et al. 2003. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U.S.A. 100: 8466-8471. doi:10.1073/pnas.1032913100. PMID: 12832613.
43. Perseghin, G., Scifo, P., De Cobelli, F., Pagliato, E., Battezzati, A., Arcelloni, C., et al. 1999. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes, 48: 1600-1606. doi:10.2337/diabetes.48.8.1600. PMID:10426379.
44. Puigserver, P., Wu, Z., Park, C.W., Graves, R., Wright, M., and Spiegelman, B.M. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell, 92: 829-839. doi:10.1016/S0092-8674(00)81410-5. PMID:9529258.
45. Puigserver, P., Rhee, J., Lin, J., Wu, Z., Yoon, J.C., Zhang, C.Y., et al. 2001. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARg coactivator-1. Mol. Cell, 8: 971-982. doi:10.1016/S1097-2765(01)00390-2. PMID:11741533.
46. Randle, P.J., Garland, P.B., Hales, C.N., and Newsholme, E.A. 1963. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, 1: 785-789. doi:10.1016/S0140-6736(63)91500-9. PMID:13990765.
47. Ritov, V.B., Menshikova, E.V., He, J., Ferrell, R.E., Goodpaster, B.H., and Kelley, D.E. 2005. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes, 54: 8-14. doi:10.2337/diabetes.54.1.8. PMID:15616005.
48. Roepstorff, C., Halberg, N., Hillig, T., Saha, A.K., Ruderman, N.B., Wojtaszewski, J.F., et al. 2005. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am. J. Physiol. Endocrinol. Metab. 288: E133-E142. doi:10.1152/ajpendo.00379.2004. PMID:15383373.
49. Russell, L.K., Mansfield, C.M., Lehman, J.J., Kovacs, A., Courtois, M., Saffitz, J.E., et al. 2004. Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor γ coactivator-1α promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ. Res. 94: 525-533. doi:10.1161/01.RES. 0000117088.36577.EB. PMID:14726475.
50. Schenk, S., and Horowitz, J.F. 2006. Coimmunoprecipitation of FAT/CD36 and CPT I in skeletal muscle increases proportionally with fat oxidation after endurance exercise training. Am. J. Physiol. Endocrinol. Metab. 291: E254-E260. doi:10.1152/ ajpendo.00051.2006. PMID:16670153.
51. Schrauwen-Hinderling, V.B., Kooi, M.E., Hesselink, M.K., Jeneson, J.A., Backes, W.H., van Echteld, C.J., et al. 2007. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI matched control subjects. Diabetologia, 50: 113-120. doi:10.1007/s00125-006-0475-1. PMID:17093944.
52. Sookoian, S., Garcia, S.I., Porto, P.I., Dieuzeide, G., Gonzalez, C.D., and Pirola, C.J. 2005. Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents. J. Mol. Endocrinol. 35: 373-380. doi:10.1677/jme.1.01837. PMID:16216916.
53. Summers, S.A. 2006. Ceramides in insulin resistance and lipotoxicity. Prog. Lipid Res. 45: 42-72. doi:10.1016/j.plipres.2005.11.002. PMID:16445986.
54. Timmers S, Schrauwen, P., and de Vogel, J. 2007. Muscular diacylglycerol metabolism and insulin resistance. Physiol Behav. 94: 242-251. doi:10.1016/j.physbeh.2007.12.002. PMID:18207474.
55. Turcotte, L.P., Swenberger, J.R., Zavitz Tucker, M., and Yee, A.J. 2001. Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats. Diabetes, 50: 1389-1396. doi:10.2337/diabetes.50.6.1389. PMID:11375340.
56. Turner, N., Bruce, C.R., Beale, S.M., Hoehn, K.L., So, T., Rolph, M.S., and Cooney, G.J. 2007. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes, 56: 2085-2092. doi:10.2337/db07-0093. PMID:17519422.
57. Unger, R.H. 2003. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology, 144: 5159-5165. doi:10.1210/en.2003-0870. PMID:12960011.
58. Winder, W.W., Arogyasami, J., Elayan, I.M., and Cartmill, D. 1990. Time course of exercise-induced decline in malonyl-CoA in different muscle types. Am. J. Physiol. 259: E266-E271. PMID:2166437.
59. Winder, W.W., Wilson, H.A., Hardie, D.G., Rasmussen, B.B., Hutber, C.A., Call, G.B., et al. 1997. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J. Appl. Physiol. 82: 219-225. doi:10.1063/1.365801. PMID:9029219.
60. Wright, D.C., Han, D.H., Garcia-Roves, P.M., Geiger, P.C., Jones, T.E., and Holloszy, J.O. 2007. Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1α expression. J. Biol. Chem. 282: 194-199. doi:10.1074/jbc.M606116200. PMID:17099248.
61. Yu, C., Chen, Y., Cline, G.W., Zhang, D., Zong, H., Wang, Y., et al. 2002. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277: 50230-50236. doi:10.1074/jbc.M200958200. PMID:12006582.